Our Neuro-Spinal Scaffold™ has the potential to provide meaningful benefit in acute thoracic spinal cord injury patients, either alone or in combination with other technologies.
Our INSPIRE 2.0 clinical study
INSPIRE 2.0 is a 20-patient clinical study designed to assess the potential benefit of the Neuro-Spinal Scaffold in comparison to current standard of care by measuring improvement on the American Spinal Injury Association (ASIA) Impairment Scale (AIS Scale) at six months post-injury.
Our future development plans:
Potential synergies with other technologies
We are evaluating the potential to use the findings we have learned from the Neuro-Spinal Scaffold in combination with other innovative technologies, including stem cells, therapeutics and electrical stimulation. Our hope is that these synergies could enable even greater gains in function and significantly improve patient outcomes.